Skip to menu Skip to content Skip to footer

2024

Journal Article

Profiling reduced expression of contractile and mitochondrial mRNAs in the human sinoatrial node vs. right atrium and predicting their suppressed expression by transcription factors and/or microRNAs

Chen, Weixuan, Aminu, Abimbola J., Yin, Zeyuan, Karaesmen, Irem, Atkinson, Andrew J., Kuniewicz, Marcin, Holda, Mateusz, Walocha, Jerzy, Perde, Filip, Molenaar, Peter and Dobrzynski, Halina (2024). Profiling reduced expression of contractile and mitochondrial mRNAs in the human sinoatrial node vs. right atrium and predicting their suppressed expression by transcription factors and/or microRNAs. International Journal of Molecular Sciences, 25 (19) 10402, 1-24. doi: 10.3390/ijms251910402

Profiling reduced expression of contractile and mitochondrial mRNAs in the human sinoatrial node vs. right atrium and predicting their suppressed expression by transcription factors and/or microRNAs

2024

Journal Article

The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis

Talamonti, Emanuela, Davegardh, Jelena, Kalinovich, Anastasia, van Beek, Sten M. M., Dehvari, Nodi, Halleskog, Carina, Bokhari, Hamza M., Hutchinson, Dana S., Ham, Seungmin, Humphrys, Laura J., Dijon, Nicola C., Motso, Aikaterini, Sandstrom, Anna, Zacharewicz, Evelyn, Mutule, Ilga, Suna, Edgars, Spura, Jana, Ditrychova, Karolina, Stoddart, Leigh A., Holliday, Nicholas D., Wright, Shane C., Lauschke, Volker M., Nielsen, Soren, Scheele, Camilla, Cheesman, Elizabeth, Hoeks, Joris, Molenaar, Peter, Summers, Roger J., Pelcman, Benjamin ... Bengtsson, Tore (2024). The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis. Molecular Metabolism, 85 101931, 101931. doi: 10.1016/j.molmet.2024.101931

The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis

2024

Book Chapter

Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders

Wong, Yee Weng, Haqqani, Haris and Molenaar, Peter (2024). Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders. Adrenoceptors. (pp. 1-49) edited by Jillian G. Baker, Martin C. Michel and Roger J. Summers. Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/164_2024_720

Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders

2023

Journal Article

Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling

Walweel, Kafa, Cheesman, Elizabeth and Molenaar, Peter (2023). Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling. Current Opinion in Physiology, 36 100719, 100719. doi: 10.1016/j.cophys.2023.100719

Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling

2023

Journal Article

Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep

See Hoe, Louise E., Bassi, Gianluigi Li, Wildi, Karin, Passmore, Margaret R., Bouquet, Mahe, Sato, Kei, Heinsar, Silver, Ainola, Carmen, Bartnikowski, Nicole, Wilson, Emily S., Hyslop, Kieran, Skeggs, Kris, Obonyo, Nchafatso G., Shuker, Tristan, Bradbury, Lucy, Palmieri, Chiara, Pedersen, Sanne-Engkilde, McDonald, Charles, Colombo, Sebastiano M., Wells, Matthew A., Reid, Janice D., O'Neill, Hollier, Livingstone, Samantha, Abbate, Gabriella, Haymet, Andrew, Jung, Jae-Seung, Sato, Noriko, James, Lynnette, He, Ting ... Fraser, John F. (2023). Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep. The Journal of Heart and Lung Transplantation, 42 (8), 1015-1029. doi: 10.1016/j.healun.2023.03.020

Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep

2022

Journal Article

Novel micro-computed tomography contrast agents to visualise the human cardiac conduction system and surrounding structures in hearts from normal, aged, and obese individuals: Iodine and graphene oxide – visualising human conduction system in normal, aged, and obese hearts

Aminu, Abimbola J., Chen, Weixuan, Yin, Zeyuan, Kuniewicz, Marcin, Walocha, Jerzy, Perde, Filip, Molenaar, Peter, Iaizzo, Paul A., Dobrzynski, Halina and Atkinson, Andrew J. (2022). Novel micro-computed tomography contrast agents to visualise the human cardiac conduction system and surrounding structures in hearts from normal, aged, and obese individuals: Iodine and graphene oxide – visualising human conduction system in normal, aged, and obese hearts. Translational Research in Anatomy, 27 100175, 1-17. doi: 10.1016/j.tria.2022.100175

Novel micro-computed tomography contrast agents to visualise the human cardiac conduction system and surrounding structures in hearts from normal, aged, and obese individuals: Iodine and graphene oxide – visualising human conduction system in normal, aged, and obese hearts

2022

Conference Publication

Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle

Spratt, M., Dashwood, A., Cheesman, E., Haqqani, H., Wong, Y., Chan, W., Laver, D. and Molenaar, P. (2022). Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD Australia, 11-14 August 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.062

Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle

2022

Conference Publication

Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheep

See Hoe, L., Bouquet, M., Hyslop, K., Passmore, M., Wells, M., Sato, K., Wilson, E., Wildi, K., Skeggs, K., Palmeri, C., Reid, J., O'Neill, H., Bartnikowski, N., Jung, J., Ainola, C., Abbate, G., Colombo, S., Obonyo, N., McDonald, C., Shuker, T., Heinsar, S., Haymet, A., Engkilde-Pedersen, S., Peart, J., Molenaar, P., Li Bassi, G., Suen, J., McGiffin, D. and Fraser, J. (2022). Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheep. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD, Australia, 11-14 August 2022. Chatswood, NSW, Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.547

Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheep

2021

Journal Article

A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death

See Hoe, Louise E., Wildi, Karin, Obonyo, Nchafatso G., Bartnikowski, Nicole, McDonald, Charles, Sato, Kei, Heinsar, Silver, Engkilde-Pedersen, Sanne, Diab, Sara, Passmore, Margaret R., Wells, Matthew A., Boon, Ai-Ching, Esguerra, Arlanna, Platts, David G., James, Lynnette, Bouquet, Mahe, Hyslop, Kieran, Shuker, Tristan, Ainola, Carmen, Colombo, Sebastiano M., Wilson, Emily S., Millar, Jonathan E., Malfertheiner, Maximillian V., Reid, Janice D., O’Neill, Hollier, Livingstone, Samantha, Abbate, Gabriella, Sato, Noriko, He, Ting ... Fraser, John F. (2021). A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death. Intensive Care Medicine Experimental, 9 (1) 60, 1-24. doi: 10.1186/s40635-021-00425-4

A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death

2021

Journal Article

Further insights into the molecular complexity of the human sinus node – The role of ‘novel’ transcription factors and microRNAs

Aminu, Abimbola J., Petkova, Maria, Atkinson, Andrew J., Yanni, Joseph, Morris, Alex D., Simms, Robert T., Chen, Weixuan, Yin, Zeyuan, Kuniewicz, Marcin, Holda, Mateusz K., Kuzmin, Vladislav S., Perde, Filip, Molenaar, Peter and Dobrzynski, Halina (2021). Further insights into the molecular complexity of the human sinus node – The role of ‘novel’ transcription factors and microRNAs. Progress in Biophysics and Molecular Biology, 166, 86-104. doi: 10.1016/j.pbiomolbio.2021.04.008

Further insights into the molecular complexity of the human sinus node – The role of ‘novel’ transcription factors and microRNAs

2021

Journal Article

Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death

Wells, Matthew A., See Hoe, Louise E., Molenaar, Peter, Pedersen, Sanne, Obonyo, Nchafatso G., McDonald, Charles I., Mo, Weilan, Bouquet, Mahè, Hyslop, Kieran, Passmore, Margaret R., Bartnikowski, Nicole, Suen, Jacky Y., Peart, Jason N., McGiffin, David C., Fraser, John F. and on behalf of the Dead Heart Project (2021). Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death. Pharmacological Research, 169 105631, 1-12. doi: 10.1016/j.phrs.2021.105631

Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death

2021

Journal Article

Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline

Dashwood, Alexander, Cheesman, Elizabeth, Wong, Yee Weng, Haqqani, Haris, Beard, Nicole, Hay, Karen, Spratt, Melanie, Chan, Wandy and Molenaar, Peter (2021). Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline. Pharmacology Research and Perspectives, 9 (3) e00760, e00760. doi: 10.1002/prp2.760

Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline

2021

Journal Article

Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, KCa1.1, in Sinus Node Function and Arrhythmia Risk

Pineda, Santiago, Nikolova-Krstevski, Vesna, Leimena, Christiana, Atkinson, Andrew J., Altekoester, Ann-Kristin, Cox, Charles D., Jacoby, Arie, Huttner, Inken G., Ju, Yue-Kun, Soka, Magdalena, Ohanian, Monique, Trivedi, Gunjan, Kalvakuri, Sreehari, Birker, Katja, Johnson, Renee, Molenaar, Peter, Kuchar, Dennis, Allen, David G., Van Helden, Dirk F., Harvey, Richard P., Hill, Adam P., Bodmer, Rolf, Vogler, Georg, Dobrzynski, Halina, Ocorr, Karen and Fatkin, Diane (2021). Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, KCa1.1, in Sinus Node Function and Arrhythmia Risk. Circulation: Genomic and Precision Medicine, 14 (2) 003144, 230-242. doi: 10.1161/CIRCGEN.120.003144

Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, KCa1.1, in Sinus Node Function and Arrhythmia Risk

2020

Journal Article

Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”

Dashwood, Alexander, Beard, Nicole, Wong, Yee Weng, Haqqani, Haris, Cheesman, Elizabeth and Molenaar, Peter (2020). Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”. ACS Pharmacology and Translational Science, 3 (6), 1422-1422. doi: 10.1021/acsptsci.0c00148

Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”

2020

Journal Article

Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

Denniss, Amanda L., Dashwood, Alexander M., Molenaar, Peter and Beard, Nicole A. (2020). Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?. Biophysical Reviews, 12 (4), 865-878. doi: 10.1007/s12551-020-00736-y

Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

2020

Journal Article

Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure

Dashwood, Alexander, Cheesman, Elizabeth, Beard, Nicole, Haqqani, Haris, Wong, Yee Weng and Molenaar, Peter (2020). Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacology and Translational Science, 3 (4) acsptsci.0c00003, 563-582. doi: 10.1021/acsptsci.0c00003

Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure

2020

Journal Article

Phenytoin reduces activity of cardiac ryanodine receptor 2; a potential mechanism for its cardioprotective action

Ashna, A., van Heiden, D. F., dos Remedios, C., Molenaar, P. and Laver, D. R. (2020). Phenytoin reduces activity of cardiac ryanodine receptor 2; a potential mechanism for its cardioprotective action. Molecular Pharmacology, 97 (4), 250-258. doi: 10.1124/mol.119.117721

Phenytoin reduces activity of cardiac ryanodine receptor 2; a potential mechanism for its cardioprotective action

2019

Journal Article

Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814

Walweel, Kafa, Gomez-Hurtado, Nieves, Rebbeck, Robyn T., Oo, Ye Wint, Beard, Nicole A., Molenaar, Peter, dos Remedios, Cris, van Helden, Dirk F., Cornea, Razvan L., Knollmann, Björn C. and Laver, Derek R. (2019). Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814. Journal of Molecular and Cellular Cardiology, 130, 96-106. doi: 10.1016/j.yjmcc.2019.03.018

Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814

2018

Conference Publication

Development of an ovine model of heart transplantation following 24-hour brain stem death

See Hoe, L., Engkilde-Pedersen, S., Obonyo, N., Wells, M., Boon, C., Bartnikowski, N., Passmore, M., McDonald, C., Black, D., Molenaar, P., Diab, S., Suen, J., Marasco, S., McGiffin, D. and Fraser, J. (2018). Development of an ovine model of heart transplantation following 24-hour brain stem death. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.111

Development of an ovine model of heart transplantation following 24-hour brain stem death

2017

Journal Article

The β3-adrenoceptor agonist mirabegron increases human atrial force through β1-adrenoceptors: an indirect mechanism?

Mo, Weilan, Michel, Martin C., Lee, Xiang Wen, Kaumann, Alberto J. and Molenaar, Peter (2017). The β3-adrenoceptor agonist mirabegron increases human atrial force through β1-adrenoceptors: an indirect mechanism?. British Journal of Pharmacology, 174 (16), 2706-2715. doi: 10.1111/bph.13897

The β3-adrenoceptor agonist mirabegron increases human atrial force through β1-adrenoceptors: an indirect mechanism?